inflammation-based risk assessment
Cardiovascular risk evaluation incorporating inflammatory biomarkers beyond traditional lipid and clinical parameters.
Full Definition
Inflammation-based risk assessment represents an evolving approach to cardiovascular risk stratification that incorporates inflammatory biomarkers alongside traditional risk factors. This method recognizes inflammation as a key driver of atherothrombosis and includes markers such as high-sensitivity C-reactive protein, interleukin-6, and other inflammatory cytokines. The approach is particularly valuable for patients at intermediate risk by traditional calculations, where inflammatory markers may help reclassify risk and guide treatment intensity. This assessment method reflects the understanding that atherosclerosis is fundamentally an inflammatory disease process.
Usage
Usage note: Specify which inflammatory markers are included when discussing this assessment method.
In Context
- "Inflammation-based risk assessment reclassified the patient from intermediate to high risk, warranting statin initiation." — cardiology consultation note
- "Guidelines increasingly incorporate inflammation-based risk assessment for borderline cases." — clinical review article